As of 4:02pm ET
| +0.38 / +0.74%|
The 7 analysts offering 12-month price forecasts for Emergent BioSolutions Inc have a median target of 45.00, with a high estimate of 55.00 and a low estimate of 40.00. The median estimate represents a -13.59% decrease from the last price of 52.08.
The current consensus among 7 polled investment analysts is to Buy stock in Emergent BioSolutions Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.